Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-13

Clinical Trial Update: Human Pilot Study - HA35 (Hyaluronan Molecular Weight 35) Dietary Supplement for Promoting Intestinal Health [NA]

View source ↗

Summary

Pilot clinical trial completed; results posted for HA35 hyaluronan dietary supplement targeting gastrointestinal microbiome health.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HA35 (Hyaluronan Molecular Weight 35) Dietary Supplement (HA35 dietary supplement)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Gastrointestinal Microbiome | NA | Status: COMPLETED | Results posted: 2020-08-13